Coruzzi G, Bertaccini G
Pharmacol Res Commun. 1987 Jan;19(1):15-27. doi: 10.1016/0031-6989(87)90029-4.
The new H2-receptor antagonist famotidine was studied to test its duration of action in comparison with ranitidine. In the conscious cat provided with gastric fistula famotidine and ranitidine, administered by bolus i.v. injection, by continuous infusion or intragastrically, had an inhibitory effect on dimaprit-induced acid secretion which lasted similarly. The only difference between the two compounds was the higher potency of famotidine. Reversibility studies carried out in the isolated gastric fundus from immature rats showed that famotidine, like ranitidine, was easily washed out even at the highest concentration tested (3 X 10(-6) M) and thus it can be considered a readily dissociable H2 antagonist in this tissue.
对新型H2受体拮抗剂法莫替丁进行了研究,以测试其与雷尼替丁相比的作用持续时间。在有意识的、设有胃瘘的猫身上,静脉推注、持续输注或胃内给予法莫替丁和雷尼替丁,对二甲弗林诱导的胃酸分泌均有抑制作用,且持续时间相似。这两种化合物之间的唯一区别在于法莫替丁的效力更高。在未成熟大鼠的离体胃底进行的可逆性研究表明,法莫替丁与雷尼替丁一样,即使在测试的最高浓度(3×10⁻⁶ M)下也很容易被洗脱,因此在该组织中可被视为一种易于解离的H2拮抗剂。